SCHEMBL3829673

SCHEMBL3829673

CO[C@H]1C[C@H](C(=O)O)N(C(=O)OC(C)(C)C)C1

nearest known ligand 0.52

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
UCHL1 P09936 1/20 0.49
HSD17B10 Q99714 1/20 0.41
NR1H2 P55055 1/20 0.38
CHRM2 P08172 1/20 0.37
CHRM1 P11229 1/20 0.37
CHRM3 P20309 1/20 0.37
CYP1A2 P05177 1/20 0.37
POLB P06746 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2C19 P33261 1/20 0.37
ATM Q13315 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.36
HTRA1 Q92743 1/20 0.35
MCL1 Q07820 3/20 0.35
BTK Q06187 1/20 0.34
HSD11B1 P28845 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL239963 1.00 UCHL1 (0.49) UCHL1HSD17B10NR1H2CHRM2CHRM1
SCHEMBL92869 1.00 UCHL1 (0.49) UCHL1HSD17B10NR1H2CHRM2CHRM1
SCHEMBL1582803 1.00 UCHL1 (0.49) UCHL1HSD17B10NR1H2CHRM2CHRM1
SCHEMBL17783113 1.00 UCHL1 (0.49) UCHL1HSD17B10NR1H2CHRM2CHRM1
SCHEMBL5480506 1.00 UCHL1 (0.49) UCHL1HSD17B10NR1H2CHRM2CHRM1
SCHEMBL8269128 1.00 UCHL1 (0.49) UCHL1HSD17B10NR1H2CHRM2CHRM1
SCHEMBL5478578 1.00 UCHL1 (0.49) UCHL1HSD17B10NR1H2CHRM2CHRM1
SCHEMBL1270226 1.00 UCHL1 (0.49) UCHL1HSD17B10NR1H2CHRM2CHRM1
SCHEMBL18577435 0.88 HSD17B10 (0.41) UCHL1HSD17B10NR1H2CHRM2CHRM1
SCHEMBL29015380 0.88 HSD17B10 (0.41) UCHL1HSD17B10NR1H2CHRM2CHRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250049780-A1 THIENOPYRROLE COMPOUNDS GILEAD SCIENCES, INC. 2025-02-13 US disclosed
US-12070455-B2 Thienopyrrole compounds GILEAD SCIENCES, INC. (US) 2024-08-27 US disclosed
US-20230365594-A1 THIENOPYRROLE COMPOUNDS GILEAD SCIENCES, INC. 2023-11-16 US disclosed
US-20230270734-A1 THIENOPYRROLE COMPOUNDS GILEAD SCIENCES, INC. 2023-08-31 US disclosed
US-20220389034-A1 THIENOPYRROLE COMPOUNDS GILEAD SCIENCES, INC. 2022-12-08 US disclosed
US-20090221546-A1 INHIBITORS OF FACTOR XA AND OTHER SERINE PROTEASES INVOLVED IN THE COAGULATION CASCADE PFIZER INC 2009-09-03 US disclosed
EP-2085391-A2 Inhibitors of factor XA and other serine proteases involved in the coagulation cascade Warner-Lambert Company LLC (US) 2009-08-05 EP disclosed
US-20080287674-A1 Inhibitors of Factor XA and Other Serine Proteases Involved in the Coagulation Cascade WARNER-LAMBERT COMPANY LLC 2008-11-20 US disclosed
US-7407974-B2 Inhibitors of factor Xa and other serine proteases involved in the coagulation cascade PFIZER INC. (US) 2008-08-05 US disclosed
US-7407972-B2 Inhibitors of factor Xa and other serine proteases involved in the coagulation cascade PFIZER INC. (US) 2008-08-05 US disclosed
EP-1671949-B1 Substituted Pyridinylamines WARNER LAMBERT CO (US) 2008-07-23 EP disclosed
US-20060264626-A1 INHIBITORS OF FACTOR Xa AND OTHER SERINE PROTEASES INVOLVED IN THE COAGULATION CASCADE WARNER-LAMBERT COMPANY LLC 2006-11-23 US disclosed
EP-1671949-A2 Substituted phenylamines and pyridinylamines WARNER-LAMBERT COMPANY LLC (US) 2006-06-21 EP disclosed
US-7030141-B2 Inhibitors of factor Xa and other serine proteases involved in the coagulation cascade WARNER-LAMBERT COMPANY LLC 2006-04-18 US disclosed
EP-1465864-B1 INHIBITORS OF FACTOR XA AND OTHER SERINE PROTEASES INVOLVED IN THE COAGULATION CASCADE WARNER LAMBERT CO (US) 2006-03-15 EP disclosed
US-20050267118-A1 Inhibitors of factor Xa and other serine proteases involved in the coagulation cascade WARNER-LAMBERT COMPANY LLC 2005-12-01 US disclosed
US-20050250815-A1 Inhibitors of fractor Xa and other serine proteases involved in the coagulation cascade WARNER-LAMBERT COMPANY LLC 2005-11-10 US disclosed
EP-1465864-A1 INHIBITORS OF FACTOR XA AND OTHER SERINE PROTEASES INVOLVED IN THE COAGULATION CASCADE Warner-Lambert Company LLC (US) 2004-10-13 EP disclosed
US-20030162787-A1 Inhibitors of factor Xa and other serine proteases involved in the coagulation cascade WARNER-LAMBERT COMPANY LLC 2003-08-28 US disclosed
WO-2003045912-A1 INHIBITORS OF FACTOR XA AND OTHER SERINE PROTEASES INVOLVED IN THE COAGULATION CASCADE WARNER-LAMBERT COMPANY LLC (US) 2003-06-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (11 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230365594-A1 THIENOPYRROLE COMPOUNDS SSB, TPMT, LCP2 UCHL1 4708/4885HSD17B10 3762/4885NR1H2 1364/4885
US-20230270734-A1 THIENOPYRROLE COMPOUNDS SSB, TPMT, LCP2 UCHL1 4708/4885HSD17B10 3762/4885NR1H2 1364/4885
US-20080287674-A1 Inhibitors of Factor XA and Other Serine Proteases Involved in the Coagulation Cascade TFPI, F11, F2 UCHL1 1350/4885HSD17B10 1622/4885NR1H2 2853/4885
US-20250049780-A1 THIENOPYRROLE COMPOUNDS SSB, TPMT, LCP2 UCHL1 4708/4885HSD17B10 3762/4885NR1H2 1364/4885
US-20050267118-A1 Inhibitors of factor Xa and other serine proteases involved in the coagulation cascade F12, TFPI, F11 UCHL1 1872/4885HSD17B10 1642/4885NR1H2 3217/4885
US-20030162787-A1 Inhibitors of factor Xa and other serine proteases involved in the coagulation cascade TFPI, F11, F12 UCHL1 2147/4885HSD17B10 1634/4885NR1H2 3100/4885
US-20090221546-A1 INHIBITORS OF FACTOR XA AND OTHER SERINE PROTEASES INVOLVED IN THE COAGULATION CASCADE F11, F2, TFPI UCHL1 1495/4885HSD17B10 1489/4885NR1H2 2778/4885
US-20050250815-A1 Inhibitors of fractor Xa and other serine proteases involved in the coagulation cascade F12, TFPI, F11 UCHL1 1532/4885HSD17B10 2542/4885NR1H2 2709/4885
US-12070455-B2 Thienopyrrole compounds SSB, TPMT, LCP2 UCHL1 4708/4885HSD17B10 3762/4885NR1H2 1364/4885
US-20060264626-A1 INHIBITORS OF FACTOR Xa AND OTHER SERINE PROTEASES INVOLVED IN THE COAGULATION CASCADE F11, F2, TFPI UCHL1 1495/4885HSD17B10 1489/4885NR1H2 2778/4885
US-20220389034-A1 THIENOPYRROLE COMPOUNDS SSB, TPMT, LCP2 UCHL1 4708/4885HSD17B10 3762/4885NR1H2 1364/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.